Press Releases

Date Title and Summary Additional Formats
Toggle Summary Harvard Bioscience to Showcase Array of New Products at Society for Neuroscience 2015 Annual Meeting in Chicago on October 18-21
Three Symposium Events Highlight Newest Electrophysiology Research Tools
View HTML
Toggle Summary Harvard Bioscience Schedules Third Quarter 2015 Conference Call for October 29 at 8:30 AM ET
HOLLISTON, Mass., Oct. 15, 2015 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, will announce results for its third quarter 2015 before market trading hours on Thursday, October 29,
View HTML
Toggle Summary Harvard Bioscience Q2 2015 Revenues Increase 7% Year-over-Year, 12% in Constant Currency, to $28.8 Million
-Conference Call To Be Held at 8:30 AM ET Today- HOLLISTON, Mass., July 30, 2015 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, today reported financial highlights for the three and six
View HTML
Toggle Summary Harvard Bioscience Schedules Second Quarter 2015 Conference Call for July 30 at 8:30 AM ET
HOLLISTON, Mass., July 16, 2015 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, will announce results for its second quarter 2015 before market trading hours on Thursday, July 30, 2015.
View HTML
Toggle Summary Harvard Bioscience to Join the Russell 3000 and Russell Global Indexes
HOLLISTON, Mass., June 23, 2015 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, is set to simultaneously join two broad-market Russell indexes.
View HTML
Toggle Summary Harvard Bioscience Reports First Quarter 2015 Financial Results
Conference Call to be Held at 11:00 AM ET Today
View HTML
Toggle Summary Harvard Bioscience Appoints James Green to the Board of Directors and Announces Retirement of Robert Dishman From the Board
HOLLISTON, Mass., April 30, 2015 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO) (the "Company"), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, appointed James Green as a Class I director of the Board of Directors to fill the new
View HTML
Toggle Summary Harvard Bioscience Schedules First Quarter 2015 Conference Call for April 30 at 11:00 AM ET
HOLLISTON, Mass., April 21, 2015 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, will announce results for its first quarter 2015 before market trading hours on Thursday, April 30, 2015.
View HTML
Toggle Summary Harvard Bioscience Fourth Quarter 2014 Non-GAAP EPS Increases 100% Versus Fourth Quarter 2013 on Record Quarterly Revenues of $30.4 Million
Acquisitions, Operational Improvements and Organic Growth Drive Results Conference Call To Be Held at 11:00 AM ET Today HOLLISTON, Mass., Feb. 26, 2015 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer and marketer of a broad range of solutions to advance
View HTML
Toggle Summary Harvard Bioscience Appoints Ryan Atienza to Vice President of Sales at Its Denville Scientific Subsidiary
Mr. Atienza Joins Executive Leadership Team Responsible for North American Sales
View HTML